Michael,

Please add my name to your list.
Thanks!
Rebecca

Rebecca Jean-Baptiste, MPA
Business Operations Manager
Board of Regents of the University System of Georgia
Atlanta, GA 30334
404-656-2224
-----Original Message-----
From: "Cappellucci, James E." <xxxxxx@PARTNERS.ORG>
Date: Thu, 5 Nov 2009 15:03:10
To: xxxxxx@hrinet.org<xxxxxx@hrinet.org>
Subject: Re: [RESADM-L] Info on starting a CRA study group

Michael, same here. Thanks.

 Jim

James Cappellucci
Sr. Grant Administrator, Grants & Contracts
Partners Healthcare/Massachusetts General Hospital
101 Huntington Avenue, 3rd Floor, Suite 300
Boston, MA  02199
Phone 617-954-9858
Fax:    617-954-9850
Main:  617-954-9309
xxxxxx@partners.org

-----Original Message-----
From: Research Administration List [mailto:xxxxxx@hrinet.org] On Behalf Of
Lynne Brody
Sent: Thursday, November 05, 2009 2:41 PM
To: xxxxxx@hrinet.org
Subject: Re: [RESADM-L] Info on starting a CRA study group

Michael,
Please keep me on your mailing list regarding your on-line study group.
Lynne Brody

Michael DeShazo wrote:
> I have been running some CRA study groups at the UW campus for a couple of
years.  I would be happy to share some info.  Perhaps a phone conversation would
be easiest.
>
> You can reach me via my cell at 425-890-3169.
>
> Cheers,
> Michael D., CRA, CTS
>
>________________________________________
> From: Research Administration List [xxxxxx@hrinet.org] On Behalf Of Lynne
Brody [xxxxxx@UNC.EDU]
> Sent: Wednesday, October 28, 2009 9:39 AM
> To: xxxxxx@hrinet.org
> Subject: [RESADM-L] Info on starting a CRA study group
>
> All,
> There is interest in setting up a CRA study group on my campus.  If you
> have participated in a CRA study group, and would be willing to give me
> some feedback and guidance, could you please email me?  I would like to
> have some information on what worked and what didn't work as well as how
> your study sessions were structured.
> Thanks so much,
> Lynne Brody
> UNC Chapel Hill
>
>
> ======================================================================
>  Instructions on how to use the RESADM-L Mailing List, including
>  subscription information and a web-searchable archive, are available
>  via our web site at http://www.hrinet.org (click on "Listserv Lists")
> ======================================================================
>
>
> ======================================================================
>  Instructions on how to use the RESADM-L Mailing List, including
>  subscription information and a web-searchable archive, are available
>  via our web site at http://www.hrinet.org (click on "Listserv Lists")
> ======================================================================
>
>

======================================================================
 Instructions on how to use the RESADM-L Mailing List, including
 subscription information and a web-searchable archive, are available
 via our web site at http://www.hrinet.org (click on "Listserv Lists")
======================================================================

The information in this e-mail is intended only for the person to whom it is
addressed. If you believe this e-mail was sent to you in error and the e-mail
contains patient information, please contact the Partners Compliance HelpLine at
http://www.partners.org/complianceline . If the e-mail was sent to you in error
but does not contain patient information, please contact the sender and properly
dispose of the e-mail.

======================================================================
 Instructions on how to use the RESADM-L Mailing List, including
 subscription information and a web-searchable archive, are available
 via our web site at http://www.hrinet.org (click on "Listserv Lists")
======================================================================

======================================================================
 Instructions on how to use the RESADM-L Mailing List, including
 subscription information and a web-searchable archive, are available
 via our web site at http://www.hrinet.org (click on "Listserv Lists")
======================================================================